Identification of beta-arrestin-1 as a diagnostic biomarker in lung cancer

BACKGROUND: Distinguishing lung adenocarcinoma (ADC) from squamous cell carcinoma (SCC) has a tremendous therapeutic implication. Sometimes, the commonly used immunohistochemistry (IHC) markers fail to discriminate between them, urging for the identification of new diagnostic biomarkers. METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Khoury, Victoria, Béland, Mélanie, Schritz, Anna, Kim, Sang-Yoon, Nazarov, Petr V., Gaboury, Louis, Sertamo, Katriina, Bernardin, François, Batutu, Roxane, Antunes, Laurent, Bennett, Catherine W., Faÿs, François, Berchem, Guy, Kim, Yeoun Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162208/
https://www.ncbi.nlm.nih.gov/pubmed/30078843
http://dx.doi.org/10.1038/s41416-018-0200-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162208/
https://www.ncbi.nlm.nih.gov/pubmed/30078843
http://dx.doi.org/10.1038/s41416-018-0200-0

Ejemplares similares